We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleFOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer.AuthorsWatkins SK; Zhu Z; Riboldi E; Shafer-Weaver KA; Stagliano KE; Sklavos MM; Ambs S; Yagita H; Hurwitz AAPublicationThe Journal of clinical investigation, 2011, Vol 121, Issue 4, p1361ISSN1558-8238Publication typearticleDOI10.1172/JCI44325